Ensysce Biosciences, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
ENSC on Nasdaq, ENSCW on OTC
Location
7946 IVanhoe Avenue, Suite 201, La Jolla, CA

There are no Buy or Sell transactions made by insiders since 11/4/2023

Ensysce Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
A. Lorne Weil 10%+ Owner $1.87M Jun 30, 2021
Daniel B. Silvers 10%+ Owner $1.75M Jun 30, 2021
William H. Chang Director, 10%+ Owner $1.27M Jun 23, 2022
Bob G. Gower Director $597K Mar 2, 2023
Lynn Kirkpatrick Chief Executive Officer, Director $186K May 25, 2022
Eric Carrera Former officer $30K Jun 30, 2021
George Peng Former officer $15K Jun 30, 2021
William Schmidt Chief Medical Officer Jun 30, 2021
Steven Robert Martin Director Jun 23, 2022
Jeffrey Millard Chief Operating Officer Jun 30, 2021
Richard Wright Chief Business Officer Jun 30, 2021
Linda Pestano Chief Development Officer Feb 4, 2022
Osman Nilab Chief Medical Officer Apr 18, 2022
David Carl Humphrey Chief Financial Officer Feb 17, 2022
Adam Levin Director Jun 23, 2022
Andrew Benton Director Jun 23, 2022
Curtis Rosebraugh Director Jun 23, 2022
Kevin Geoffrey Birkett Chief Commercial Officer Feb 17, 2022
Lee Rauch Director Jun 23, 2022

Recent Insider Transactions by Companies or Individuals for Ensysce Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.